```html

Acute Urinary Tract Infection (UTI)

Overview

An acute urinary tract infection (UTI) is a sudden bacterial (or, rarely, fungal) infection of any part of the urinary system—most commonly the bladder (cystitis) or the urethra (urethritis). It is characterised by rapid onset of symptoms such as urgency, frequency, and burning during urination.

UTIs affect people of all ages, but the highest incidence is seen in women of reproductive age. According to the U.S. Centers for Disease Control and Prevention (CDC), about 8–10 million outpatient visits each year in the United States are due to uncomplicated UTIs, making it one of the most common bacterial infections worldwide.

Globally, an estimated 150 million cases per year are reported, representing a substantial burden on healthcare systems and a leading cause of antibiotic prescriptions.<sup>[1] WHO, 2023</sup>

Symptoms

Symptoms can develop within hours to a couple of days after bacterial colonisation. The presentation varies depending on the site of infection (bladder vs. urethra vs. kidneys) and on patient factors such as age and sex.

Lower‑tract (Bladder & Urethra) Symptoms

• Urinary urgency – a sudden, strong need to urinate.
• Frequency – needing to urinate more often than usual (often >8 times per day).
• Dysuria – burning or painful sensation during urination.
• Hematuria – visible or microscopic blood in the urine.
• Cloudy, foul‑smelling urine – due to bacterial by‑products.
• Pain or pressure in the lower abdomen or suprapubic region.

Upper‑tract (Kidney) Symptoms – May Indicate Pyelonephritis

• Fever ≥38°C (100.4°F) or chills.
• Flank or back pain, often unilateral.
• Nausea and vomiting.
• General malaise or fatigue.

Special Populations

• Elderly patients may present with confusion, delirium, or a sudden decline in functional status rather than classic dysuria.
• Pregnant women often have increased urinary frequency and may have mild discomfort that masks infection; any suspicion warrants prompt evaluation.

Causes and Risk Factors

Primary Causative Organisms

• Escherichia coli (≈70‑90% of uncomplicated UTIs) – originates from the gastrointestinal tract and adheres to urothelium via pili.
• Other Gram‑negative bacteria: Klebsiella pneumoniae, Proteus mirabilis, Enterobacter spp.
• Gram‑positive bacteria: Enterococcus faecalis, Staphylococcus saprophyticus (particularly in sexually active young women).
• Fungal pathogens (e.g., Candida albicans) are uncommon and usually occur in immunocompromised hosts or after prolonged antibiotic use.

Risk Factors

• Female anatomy – shorter urethra and proximity to the anus.
• Sexual activity – especially intercourse (“honeymoon cystitis”).
• Use of spermicides or diaphragm contraception.
• Recent urinary catheterisation or instrumentation.
• Pregnancy – hormonal changes and urinary stasis.
• Menopause – decreased estrogen leads to thinning of the urothelium.
• Urinary tract abnormalities (e.g., stones, reflux, obstruction).
• Diabetes mellitus – glucosuria promotes bacterial growth.
• Immunosuppression (e.g., corticosteroids, HIV).
• Previous UTI – recurrence risk increases with each episode.

Diagnosis

Accurate diagnosis hinges on a clear history, focused physical examination, and targeted laboratory testing.

Clinical Evaluation

• Assess symptom pattern, duration, and severity.
• Check for fever, flank tenderness, or signs of systemic infection.
• In women, a brief pelvic exam may be performed to rule out vaginitis or sexually transmitted infections that mimic UTI.

Laboratory Tests

• Urinalysis (dipstick): detects leukocyte esterase, nitrites (suggestive of Gram‑negative bacteria), blood, and leukocytes.
• Urine microscopy: visualises pyuria (>10 WBC/HPF) and bacteriuria.
• Urine culture (gold standard):
  • Quantitative culture >10⁵ CFU/mL of a single organism confirms infection for uncomplicated cases.
  • For symptomatic women, a lower threshold (≥10³ CFU/mL) may be acceptable.
• Pregnancy test in women of child‑bearing age if the status is unknown.
• In suspected pyelonephritis, obtain blood cultures and consider imaging (ultrasound or CT) to assess for obstruction or abscess.

When Cultures May Not Be Needed

Guidelines from the Mayo Clinic and the Infectious Diseases Society of America (IDSA) suggest that in uncomplicated cystitis in otherwise healthy, non‑pregnant women, empirical treatment without urine culture is acceptable if typical symptoms are present.

Treatment Options

The mainstay of therapy is antimicrobial agents, complemented by measures that relieve symptoms and prevent recurrence.

Antibiotic Therapy

First‑line (Uncomplicated)	Duration
Trimethoprim‑sulfamethoxazole (TMP‑SMX) 160/800 mg PO BID	3 days
Nitrofurantoin macrocrystals 100 mg PO BID	5 days
Pivmecillinam 400 mg PO TID (where available)	5 days

For patients with known local resistance, allergies, or contraindications, alternative agents include:

• Fosfomycin 3 g PO single dose.
• Fluoroquinolones (e.g., ciprofloxacin 250 mg PO BID) – reserved due to rising resistance and risk of tendon toxicity.<sup>[2] FDA, 2022</sup>
• Beta‑lactams (amoxicillin‑clavulanate, cefdinir) – longer courses (5‑7 days) may be required.

Special Populations

• Pregnant women: Use nitrofurantoin (avoiding the 1st trimester), amoxicillin‑clavulanate, or cefazolin based on susceptibility.
• Elderly or those with renal impairment: Dose-adjusted nitrofurantoin or TMP‑SMX; avoid nitrofurantoin if eGFR <30 mL/min.
• Recurrent UTI prophylaxis:
  • Low‑dose TMP‑SMX 80/400 mg nightly for 6‑12 months.
  • Post‑coital single‑dose TMP‑SMX.
  • Monthly single‑dose fosfomycin.

Symptomatic Relief

• Analgesic/antispasmodic agents (e.g., phenazopyridine 200 mg PO QID for up to 2 days) – helps with dysuria but does not treat infection.
• Increased fluid intake to promote frequent voiding.

Procedural Interventions

Procedures are rarely needed for uncomplicated acute UTI, but consider them when obstruction is present:

• Insertion of a Foley catheter (short‑term) for urinary retention.
• Ureteral stent placement for obstructive stones or strictures.
• Drainage of perinephric abscess if identified on imaging.

Living with Acute Urinary Tract Infection

Daily Management Tips

• Hydration: Aim for at least 2‑2.5 L of water daily unless contraindicated.
• Void Frequently: Do not "hold it" – empty bladder every 2‑3 hours.
• Heat Therapy: A warm sitz‑bath can ease suprapubic discomfort.
• Avoid Irritants: Limit caffeine, alcohol, spicy foods, and artificial sweeteners that may worsen bladder irritation.
• Proper Hygiene: Wipe front‑to‑back, urinate after intercourse, and avoid douches or scented feminine products.
• Complete Antibiotic Course: Even if symptoms improve, finish the prescribed regimen to prevent resistance and relapse.
• Monitor Symptoms: Keep a simple log of temperature, pain level, and urinary frequency; report worsening signs promptly.

When to Contact Your Provider

If after 48‑72 hours of appropriate antibiotics you experience:

• No improvement in dysuria or frequency.
• New onset fever, chills, or flank pain.
• Visible blood clots or sudden inability to urinate.

Prevention

Preventive strategies combine behavioural modifications, medical interventions, and, when appropriate, prophylactic antibiotics.

Behavioral Measures

• Drink enough fluids to produce at least 1.5 L of urine per day.
• Urinate before and after sexual activity.
• Choose cotton underwear; avoid tight‑fitting synthetic garments.
• Consider probiotic products containing Lactobacillus rhamnosus or L. reuteri, which have modest evidence for reducing recurrence.<sup>[3] JAMA Netw Open, 2021</sup>

Medical Prevention

• Topical estrogen therapy for post‑menopausal women reduces recurrent UTIs (approved by FDA).
• Vaccines under development (e.g., Uro-Vaxom) show promise but are not yet standard of care.
• For patients with structural anomalies, surgical correction (e.g., removal of stones, correction of reflux) lowers infection risk.

Prophylactic Antibiotics

Reserved for women with ≥3 infections per year despite lifestyle measures. Discuss risks of resistance with your clinician before initiating.

Complications

If left untreated or inadequately treated, an acute UTI can progress to serious conditions:

• Acute pyelonephritis – infection of the kidney; may lead to sepsis, renal scarring, or loss of renal function.
• Urosepsis – systemic inflammatory response to infection; high mortality if not promptly managed.
• Chronic kidney disease – recurrent pyelonephritis can cause irreversible damage.
• Obstructive complications – formation of ureteral strictures or bladder contracture.
• Fetal complications in pregnancy: preterm labor, low birth weight, and increased risk of neonatal sepsis.<sup>[4] ACOG, 2022</sup>

When to Seek Emergency Care

---

References

1. World Health Organization. “Urinary Tract Infections: Global Burden and Antimicrobial Resistance.” 2023.
2. U.S. Food and Drug Administration. “Safety Communications – Fluoroquinolone Antibiotics.” 2022.
3. Stapleton AE, et al. “Effect of Oral Probiotics on Recurrent Urinary Tract Infection.” JAMA Netw Open. 2021;4(9):e2121235.
4. American College of Obstetricians and Gynecologists. “UTI Management in Pregnancy.” Practice Bulletin No. 227, 2022.

```